FIELD: medicine, pharmacy. SUBSTANCE: invention relates to composition in solid medicinal form eliciting anti-inflammatory activity. Invention proposes composition containing 4-hydroxy-2-methyl-3-[N-(2-pyridinyl)-carboxamide] -2H-1,2-benzothiazine-1,1-dioxide and magnesium stearate and microcrystalline cellulose or lactose and starch or aerosil, or magnesium or calcium stearate, or polyethylene glycol 4000 (PEG 4000) as additional accessory substances taken in the ratio given in the invention claim. Composition comprises envelope consisting of acetylphthalyl cellulose, ethyl alcohol, chloroform, dye tropeolin-0 or acid red 2C and vaseline or sunflower oil. Invention provides making tablets with rational vehicles and accessory substances enhancing anti-inflammatory activity and decreasing ulcerogenic effect. EFFECT: valuable medicinal properties of composition. 2 cl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF BENZATHIAZINES | 1991 |
|
RU2032679C1 |
PHARMACEUTICAL COMPOSITION OF FUNGICIDAL ACTIVITY AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2188019C1 |
PROCESS FOR PRODUCTION OF N-(2-PYRIDYL)-2-METHYL-4-HYDROXY-2H-1,2-BENZOTHIAZINE- 3-CARBOXAMIDE-1,1-DIOXIDE | 1990 |
|
SU1764296A1 |
MEDICATION BASED ON DRY EXTRACTS OF MEDICINAL PLANTS AND METHOD OF OBTAINING THEREOF (VERSIONS) | 2012 |
|
RU2563190C2 |
AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
ANTIBACTERIAL AGENT AS TABLET AND METHOD OF ITS PREPARING | 2001 |
|
RU2199314C1 |
CYCLIC SULFONES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF ITS PREPARING | 1996 |
|
RU2161616C2 |
METHOD OF PRODUCING N-AMINOMETHYLBENZOYL DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACED-ADDITIVE SALTS WITH INORGANIC ACID | 0 |
|
SU1538896A3 |
METHOD OF OBTAINING HIGH-PURITY MELOXICAM AND MELOXICAM POTASSIUM SALT | 2005 |
|
RU2394032C2 |
ANTIBACTERIAL AGENT AND METHOD OF ITS PREPARING | 1999 |
|
RU2149632C1 |
Authors
Dates
2003-01-20—Published
2001-12-13—Filed